Abstract

Neonatal screening programs play a pivotal role in early diagnosis and intervention for various genetic, metabolic, and endocrine disorders in newborns. These programs are essential for preventing severe health complications, improving child development, and reducing infant mortality. However, disparities in access to neonatal screening continue to persist, particularly in low-resource settings and among marginalized populations. Ensuring equity in neonatal screening is critical for maximizing health outcomes and preventing health disparities. This paper examines the challenges and strategies related to equitable access to neonatal screening, focusing on factors such as healthcare infrastructure, socioeconomic status, and geographic location. It explores the role of policy, international guidelines, and public health initiatives in addressing these disparities. By advocating for inclusive, accessible, and cost-effective screening programs, this study emphasizes the importance of ensuring that all newborns, regardless of background, receive timely and appropriate screening. Ultimately, achieving equity in neonatal screening is fundamental to promoting universal health and ensuring that every child has the opportunity for a healthy start in life.